SCA takes over Micronics
The acquisition allows Sony to boost up its own research and development, particularly for Point of Care diagnostic equipment and also to commercialize these products. Micronics will become
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.